Literature DB >> 12407489

Infection with retroviruses other than HIV-1 in Spain: a retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II.

Carlos Toro1, Vincent Soriano, Concepción Tuset, Antonio Aguilera, Estrella Caballero, Raul Ortiz de Lejarazu, Berta Rodés.   

Abstract

HIV-2, human T-cell lymphotropic virus (HTLV)-I, and HTLV-II infections are currently circulating in Spain with no evidence of an increase in the number of reported cases over time. Up to June 2002, a total of 106, 53, and 460 cases of HIV-2, HTLV-I, and HTLV-II infection, respectively, have been identified in Spain. Most HIV-2-infected and HTLV-I-infected individuals are immigrants who come from endemic areas or are Spaniards with a past history of travel to or sexual contacts with persons originating in those areas. In contrast, HTLV-II infection is mainly limited to native intravenous drug users who are frequently coinfected with HIV-1.

Entities:  

Mesh:

Year:  2002        PMID: 12407489     DOI: 10.1310/c0xr-f0q4-vr3x-yrbn

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  2 in total

1.  An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.

Authors:  F Damond; A Benard; Claudia Balotta; Jürg Böni; Matthew Cotten; Vitor Duque; Bridget Ferns; Jeremy Garson; Perpetua Gomes; Fátima Gonçalves; Geoffrey Gottlieb; Bernd Kupfer; Jean Ruelle; Berta Rodes; Vicente Soriano; Mark Wainberg; Audrey Taieb; Sophie Matheron; Genevieve Chene; Francoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

2.  Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.

Authors:  Florence Damond; Antoine Benard; Jean Ruelle; Abraham Alabi; Bernd Kupfer; Perpetua Gomes; Berta Rodes; Jan Albert; Jürg Böni; Jeremy Garson; Bridget Ferns; Sophie Matheron; Geneviève Chene; Françoise Brun-Vezinet
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.